ArticleScientific reports2025
Machine learning model for early diagnosis of breast cancer based on PiRNA expression with CA153.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of an interpretable model based on ultrasound radiomics for predicting Ki-67 expression levels in breast cancer.Translational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
PIWI-interacting RNAs (piRNAs) have been implicated in the biological processes of various cancers. This study aimed to investigate the diagnostic potential of circulating piRNAs in breast cancer (BC) using machine learning (ML) frameworks. A serum tri-piRNA signature (piR-139966, piR-2572505, piR-2570061) was selected via piRNA sequencing, validated by qPCR, and then analyzed in combination with related clinical factors. Predictive ML models for early diagnosis of BC combining piRNA expression with CA153 were constructed using 10 ML algorithms and evaluated by 8 performance metrics. Serum levels of piR-139966, piR-2572505, and piR-2570061 were significantly upregulated in early-stage BC patients compared to matched healthy controls. This tri-piRNA panel demonstrated enhanced diagnostic precision for BC detection and exhibited complementary value to CA153 measurements, whether used alone or combined. Through systematic ML optimization, we developed a stratified diagnostic model where XGBoost algorithm showed optimal performance in both training and validation cohorts for early-stage BC identification. With XGBoost algorithms applied to piRNA expression along with CA153, we developed and validated a predictive ML model with superior diagnostic accuracy compared to conventional approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.